• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Introduction to 2-Methyl-4-dibenzylaminobenzaldehyde-1,1-diphenylhydrazone (CAS No. 103079-11-4)

2-Methyl-4-dibenzylaminobenzaldehyde-1,1-diphenylhydrazone, identified by the CAS number 103079-11-4, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound belongs to the class of hydrazones, which are widely recognized for their versatile applications in medicinal chemistry due to their unique structural and electronic properties. The presence of multiple aromatic rings and functional groups in its molecular structure endows it with a rich chemical reactivity, making it a valuable scaffold for the development of novel bioactive molecules.

The name of the compound highlights several key structural features that are critical for understanding its potential applications. The methyl group at the 2-position of the benzene ring introduces steric hindrance, which can influence the compound's interaction with biological targets. The dibenzylamine moiety at the 4-position serves as a nitrogen-rich group, often involved in hydrogen bonding interactions, which are crucial for binding affinity in drug design. Additionally, the 1,1-diphenylhydrazone moiety is a distinctive feature that contributes to the compound's solubility and stability under various conditions. These structural elements collectively contribute to the compound's potential as a building block for pharmacological investigations.

In recent years, there has been a growing interest in exploring new derivatives of hydrazones for their therapeutic potential. The latest research in this area has demonstrated that hydrazones can exhibit a wide range of biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. The structural diversity of hydrazones allows for fine-tuning their pharmacological profiles by modifying specific functional groups. For instance, studies have shown that modifications at the aldehyde or hydrazone positions can significantly alter the compound's bioactivity and selectivity.

One particularly compelling aspect of 2-Methyl-4-dibenzylaminobenzaldehyde-1,1-diphenylhydrazone is its potential as an intermediate in the synthesis of more complex pharmacophores. The compound's ability to undergo further functionalization makes it an attractive candidate for library screening and high-throughput virtual screening (HTVS) campaigns. These approaches are increasingly employed in drug discovery pipelines to identify novel lead compounds with desired biological properties. The hydrazone core is particularly amenable to such modifications due to its reactivity with various electrophiles and nucleophiles.

The chemical synthesis of this compound involves multi-step reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate aldehydes and hydrazines, followed by purification steps such as recrystallization or column chromatography. Advances in synthetic methodologies have enabled the efficient preparation of complex hydrazones like this one, facilitating their use in downstream applications.

Beyond its synthetic utility, 2-Methyl-4-dibenzylaminobenzaldehyde-1,1-diphenylhydrazone has shown promise in preliminary biological assays. For example, studies have indicated that derivatives of this compound may interact with enzymes or receptors involved in disease pathways. While further research is needed to fully elucidate its mechanism of action, these initial findings underscore its potential as a starting point for drug development. The aromatic nature of its structure suggests interactions with π-systems in biological targets, which could be exploited for therapeutic benefit.

The pharmacokinetic properties of this compound are also an important consideration in its development as a drug candidate. Factors such as solubility, stability, and metabolic clearance can significantly impact its efficacy and safety profile. Computational modeling techniques are increasingly used to predict these properties before experimental validation is conducted. Such approaches help streamline the drug discovery process by identifying promising candidates early on.

In conclusion,2-Methyl-4-dibenzylaminobenzaldehyde-1,1-diphenylhydrazone (CAS No. 103079-11-4) represents a fascinating example of how structural complexity can be leveraged to develop novel bioactive molecules. Its unique combination of functional groups makes it a versatile scaffold for medicinal chemistry investigations, particularly in the context of exploring new therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound, it is likely to remain a valuable tool in both academic and industrial settings.

• 90146-33-1(Benzaldehyde, 4-(diphenylamino)-2,5-dimethyl-, 2,2-di-1-naphthalenylhydrazone)
• 82532-79-4(Benzaldehyde, 4-[bis(4-methylphenyl)amino]-, methylphenylhydrazone)
• 87755-83-7(Benzaldehyde, 4-(methylphenylamino)-, methylphenylhydrazone)
• 82532-76-1(Benzaldehyde,4-(diphenylamino)-, 2,2-diphenylhydrazone)
• 83992-95-4(4-Bis(4-methylphenyl)aminobenzaldehyde-1,1-diphenyl-hydrazone)
• 71135-02-9(Benzaldehyde,4-(dimethylamino)-, 2,2-diphenylhydrazone)
• 90146-28-4(Benzaldehyde, 4-(dimethylamino)-2,5-dimethyl-, 2-(1-naphthalenyl)-2-phenylhydrazone)
• 82532-74-9(Benzaldehyde, 4-(diphenylamino)-, methylphenylhydrazone)
• 76344-22-4(1,2-Benzenedicarboxaldehyde, bis(diphenylhydrazone))
• 87755-84-8(Benzaldehyde, 4-(methylphenylamino)-, diphenylhydrazone)